“Importantly, if we were to develop a more nuanced understanding of some of these factors, we would be able to develop more cogent therapeutic approaches, including personalized treatment approaches,” they say.
This research had no commercial funding. Dr. Bassiri and Dr. Dulek have indicated no relevant disclosures.
- Dulek D, Fuhlbrigge RC, Tribble AC, et al. Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute COVID-19 in pediatric patients. J Pediatric Infect Dis Soc. 2020 Aug 18;piaa098. Online ahead of print.